Compare EIC & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EIC | INGN |
|---|---|---|
| Founded | N/A | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.7M | 173.2M |
| IPO Year | N/A | 2013 |
| Metric | EIC | INGN |
|---|---|---|
| Price | $9.51 | $6.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $14.00 | $11.00 |
| AVG Volume (30 Days) | 184.6K | ★ 302.4K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | ★ 13.84% | N/A |
| EPS Growth | N/A | ★ 43.42 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $348,668,000.00 |
| Revenue This Year | $9.27 | $7.92 |
| Revenue Next Year | N/A | $7.86 |
| P/E Ratio | $9.08 | ★ N/A |
| Revenue Growth | N/A | ★ 3.86 |
| 52 Week Low | $9.33 | $5.34 |
| 52 Week High | $15.22 | $9.13 |
| Indicator | EIC | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 32.10 | 49.84 |
| Support Level | $9.33 | $6.12 |
| Resistance Level | $10.15 | $6.19 |
| Average True Range (ATR) | 0.21 | 0.35 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 20.56 | 57.97 |
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.